BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2012
View Archived Issues
Researchers at Leo Pharma patent novel ingenol compounds
Read More
Candidate Syntaxin drug for acromegaly has new mode of action
Read More
New NK3 receptor antagonists presented by Roche
Read More
New antifungals prepared at Janssen Pharmaceutica
Read More
Eutropics Pharmaceuticals discloses novel Mcl-1/Bcl-XL inhibitors
Read More
New IGF-I receptor inhibitors reported by Boehringer Ingelheim
Read More
Janssen Pharmaceutica divulges new BACE1 inhibitors
Read More
Belgian-Dutch collaboration yields candidate biomarker for use in kidney transplant recipients
Read More
Novel OGA inhibitors designed
Read More
BioCryst reports on two phase II trials of BCX-4208
Read More
Data presented on sustained-release plug for glaucoma
Read More
Recruitment begins in phase II NKTR-181 trial
Read More
First preclinical candidate drug selected in osteoarthritis alliance
Read More
Merck & Co. provides update on anti-HIV drug development
Read More
Dynavax submits MAA for Heplisav hepatitis B vaccine
Read More
Sarepta drug shows clinical benefit in Duchenne muscular dystrophy
Read More
Ongoing conference features new data on anti-HIV/HSV combination gel
Read More
Pfizer reports topline results from first of four phase III bapineuzumab studies
Read More
First patient treated in study of subcutaneous Debio-8206
Read More
Biofrontera holds meeting with FDA regarding planned application for Ameluz
Read More
FDA grants priority review to enzalutamide NDA
Read More
FDA issues safety communication regarding Ampyra
Read More
Anticancer drug shows promise to treat Alzheimer's disease
Read More
Psyadon halts ecopipam study based on promising interim results
Read More
SRI receives NIAID grant for development of bioadhesive gel
Read More
European Commission approves combination tablet for type 2 diabetes
Read More